Kane Biotech reports Q2 results

1 week ago 1
  • Kane Biotech press release (OTCQB:KNBIF): Q2 total revenue was C$27,997 compared to C$620,437 in the three months ended June 30, 2024.
  • Net loss was C$(348,541) compared to a net loss of C$(1,215,996) for the quarter ended June 30, 2024.

Recommended For You

More Trending News

Read Entire Article